Saxenda: payments to doctors
Payments that named Saxenda as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $11.4M
- Providers
- 45,962
- Transactions
- 190,536
- Average per transaction
- $60
The per-transaction average — $60 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 45,962 providers the average total is $249, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novo Nordisk | $11,211,470 | 98.1% |
| Novo Nordisk AS | $218,015 | 1.9% |
| Novo Nordisk Health Care AG | $4,760 | 0.0% |